See all studies
8/17
Safety
Early treatment study
Mohana et al., medRxiv, doi:10.1101/2020.08.16.20175752 (Preprint) (not included in the study count)
Hydroxych loroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia
Safety study of 2,733 patients in Saudi Arabia showing HC Q in mild to moderate cases in an outpatient setting, within the protocol recommendation and inclusion/exclusion criteria, is safe, highly tolerable, and has minimal side effects. No ICU admission or deaths were reported.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.
Submit